ENGAIN was established in Dec 2011, they are a high tech medical device company based on bio-macromolecules synthesis technology. Their vision is to be the leading player of advanced technology.
· Non-invasive Continuous Glucose Monitoring System with
· Ultra-fine Particles Mask
· Radiopaque Embolic Agent
The followings are some of their recent development
· Commercialization: N.I. continuous glucose monitoring system
· Joint development of NanoFiber filter with ShinShu University of Japan
· Developing next generation Bio-sensor for glucose measurement